Literature DB >> 3117613

Production of lymphokines by HBsAg-reactive human T cell clones upon antigenic stimulation.

A Nonomura1, G Ohta.   

Abstract

The production of lymphokines by human HBsAg-reactive T cell clones was examined. The five clones were successfully obtained from an HBV-vaccinated person and were composed exclusively of Leu 1+, Leu 2a, Leu 3a+, helper/inducer T cells. Three of the five showed significant levels of gamma interferon (IFN-gamma) production and all of the five produced B cell growth factor (BCGF) by stimulation with HBsAg but not with unrelated antigens, including influenza A virus antigens and PPD, whereas no detectable amount of interleukin-2 was found in all clone supernatants. The magnitude of HBsAg-induced cell proliferation did not parallel the levels of IFN-gamma production among the clones. These results indicate from the view of lymphokine production that the HBsAg-reactive helper/inducer T cell clones were heterogeneous even from a source of the peripheral blood sample, and further suggest that the clones play important roles in the immune reaction against HBV infection by producing lymphokines upon antigenic stimulation.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3117613     DOI: 10.1007/bf02773813

Source DB:  PubMed          Journal:  Gastroenterol Jpn        ISSN: 0435-1339


  11 in total

1.  T cell growth factor: parameters of production and a quantitative microassay for activity.

Authors:  S Gillis; M M Ferm; W Ou; K A Smith
Journal:  J Immunol       Date:  1978-06       Impact factor: 5.422

Review 2.  Interferons with special emphasis on the immune system.

Authors:  R M Friedman; S N Vogel
Journal:  Adv Immunol       Date:  1983       Impact factor: 3.543

3.  Cytopathic effect inhibition assay for interferon: microculture plate assay.

Authors:  J A Armstrong
Journal:  Methods Enzymol       Date:  1981       Impact factor: 1.600

Review 4.  T-cell growth factor and the culture of cloned functional T cells.

Authors:  K A Smith; F W Ruscetti
Journal:  Adv Immunol       Date:  1981       Impact factor: 3.543

5.  Disordered immunoregulatory functions in patients with chronic active hepatitis.

Authors:  A Nonomura; M Tanino; H Kurumaya; G Ohta; Y Kato; K Kobayashi
Journal:  Clin Exp Immunol       Date:  1982-03       Impact factor: 4.330

6.  Soluble factor activation of human B lymphocytes.

Authors:  R J Ford; S R Mehta; D Franzini; R Montagna; L B Lachman; A L Maizel
Journal:  Nature       Date:  1981-11-19       Impact factor: 49.962

7.  Proliferative responses of normal human B lymphocytes. Development of an assay system for human B cell growth factor (BCGF).

Authors:  A Muraguchi; A S Fauci
Journal:  J Immunol       Date:  1982-09       Impact factor: 5.422

8.  Antibody to staphylococcal enterotoxin A-induced human immune interferon (IFN gamma).

Authors:  M P Langford; D A Weigent; J A Georgiades; H M Johnson; G J Stanton
Journal:  J Immunol       Date:  1981-04       Impact factor: 5.422

9.  Dissociated production of interleukin-2 and immune (gamma) interferon by phytohaemagglutinin stimulated lymphocytes in healthy infants.

Authors:  T Miyawaki; H Seki; K Taga; H Sato; N Taniguchi
Journal:  Clin Exp Immunol       Date:  1985-02       Impact factor: 4.330

10.  Differential sensitivity of human B cell subsets to activation signals delivered by anti-mu antibody and proliferative signals delivered by a monoclonal B cell growth factor.

Authors:  A Muraguchi; J L Butler; J H Kehrl; A S Fauci
Journal:  J Exp Med       Date:  1983-02-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.